PRKN and myopathy: Our results suggest that impaired mitochondrial function in CLI patients is linked to dysregulation of the mitochondrial quality control system PINK1-Parkin-mediated mitophagy, which may be of importance for future development of novel therapeutic strategies targeting the myopathy associated with CLI.